NCT07724821

Brief Summary

This project will test the feasibility, acceptability, and preliminary effects of a tailored cardiovascular (CV) health promotion program, Mom♥Health2.0, leveraging childcare centers as platforms for maternal engagement. Investigators will enroll 50 mothers from Childcare Centers in New York City.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
48mo left

Started Aug 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

August 24, 2026

Expected
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2029

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2030

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

2.9 years

First QC Date

July 21, 2026

Last Update Submit

July 21, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility: Program Completion

    Feasibility is measured as the number of participants with 80% participant program completion.

    Up to Week 10 (End of Intervention)

  • Feasibility: Appointment Scheduling

    Feasibility is measured as the number of participants with 80% clinic/social services appointment scheduled for identified needs

    Up to Week 18 (End of Study)

  • Acceptability: Consent Rate

    Acceptability is measured as the consent rate of eligible mothers; the aim is 80%.

    Baseline

  • Acceptability: Client Satisfaction

    Acceptability is measured as the number of participants with an average post-intervention Client Satisfaction Questionnaire-8 score ≥ 25. The questionnaire comprises 8-items and assesses program satisfaction in: quality, whether it has met individual needs, if the individual would recommend to others. The total range is 8-32; a score of 25 is an established cutoff for good satisfaction.

    Week 18 (End of Study)

Secondary Outcomes (3)

  • Change in Life's Essential Eight Score

    Baseline, Week 18 (End of Study)

  • Change in Perceived Stress Scale (PSS-4) Score

    Baseline, Week 18 (End of Study)

  • Change in Patient Health Questionnaire (PHQ-8) Score

    Baseline, Week 18 (End of Study)

Study Arms (1)

Mothers

EXPERIMENTAL

Mothers will receive the Mom♥Health2.0 intervention, which consists of evidence-based lifestyle counseling and community-to-clinic/social services linkage.

Behavioral: Mom♥Health2.0

Interventions

Mom♥Health2.0BEHAVIORAL

The 10 week intervention will include 1) 8 individual weekly phone calls to mothers that consist of education and counseling related to a hearth healthy lifestyle as well as strategies for stress reduction; 2) two in-person sessions to be held in the designated Childcare Centers that will focus on providing practical tips for self-care and as platform for connection among mothers; 3) referral to clinical care for identified needs (e.g., elevated blood pressure); 4) referral to available social resources (e.g., food pantry for identified food insecurity).

Mothers

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female adults, age 18-49 years.
  • Mothers, self-identified as primary caregivers of children ≤ 5 years (biological, adopted, fostered) whose child(ren) attend formal childcare (no home daycare);
  • English or Spanish speaking.
  • Willing and able to consent to participation.

You may not qualify if:

  • Significant cognitive impairment (evident during screening)
  • Current participation in another behavioral clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

Study Officials

  • Milla Arabadjian, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start (Estimated)

August 24, 2026

Primary Completion (Estimated)

August 1, 2029

Study Completion (Estimated)

August 1, 2030

Last Updated

July 24, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the researcher who provides a methodologically sound proposal executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Milla.arabadjian@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
Requests should be directed to Milla.arabadjian@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.

Locations